The medical world is seeing a major shift in diabetes therapy with the emergence of GLP-1 skin applications. These systems offer a seemingly more user-friendly alternative to subcutaneous administrations of GLP-1 receptor agonists, lessening the requirement of daily needle pricks. The innovation